Ramin Davoudi, MD
Clinical Cardiac Electrophysiology · Middletown, RINPI 1851356216
Payments from drug & device makers
What this record shows
Abbott accounts for 80.6% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $2,169, more than ten times the $32 reported in 2019.
Across 42 payments — averaging $95.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$633
- Boston Scientific$121
- Cardiva Medical, Inc.$24
Across 149 payments — averaging $2852.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$416K
- Biotronik Inc.$9K
What the payments were for
- Travel & lodging$1,90547%
- Food & beverage$2,10753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $3,235 |
| Medtronic(2 entities) | 14 | $633 |
| Boston Scientific | 1 | $121 |
| Cardiva Medical, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical cardiac electrophysiology providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 227 | $203,730 |
| XareltoRivaroxaban | 27 | $30,676 |
| EntrestoSacubitril/Valsartan | 32 | $29,041 |
| Metoprolol Succinate | 224 | $3,900 |
| SotalolSotalol Hcl | 68 | $1,743 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 33 | $798 |
| Amiodarone Hcl | 48 | $740 |
| Flecainide Acetate | 16 | $716 |
| Amlodipine Besylate | 58 | $690 |
| Losartan Potassium | 29 | $412 |
| Lisinopril | 42 | $372 |
| Valsartan | 17 | $363 |
| Atorvastatin Calcium | 31 | $318 |
| Metoprolol Tartrate | 26 | $304 |
| Digoxin | 18 | $259 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Middletown
- Michael WuEast Providence$18K
- Daniel PhilbinProvidence$15K
- David ShimProvidence$14K
- Xiaoxiao QianProvidence$13K
- Malcolm KirkWoonsocket$11K
- John RodriguezLincoln$9K
- Arnoldas GiedrimasProvidence$7K
- Carlos CuelloProvidence$7K
- Jerome KalifaProvidence$6K
- Estelle TorbeyEast Providence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.